0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.00%
Revenue growth of 0.00% while 0425.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
0.00%
Gross profit growth of 0.00% while 0425.HK is zero. Bruce Berkowitz would see if minimal improvements could expand further.
0.00%
EBIT growth of 0.00% while 0425.HK is zero. Bruce Berkowitz would see if small gains can be scaled further.
-0.00%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
No Data
No Data available this quarter, please select a different quarter.
-512.90%
Negative EPS growth while 0425.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-512.90%
Negative diluted EPS growth while 0425.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-71.49%
Share reduction while 0425.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-71.49%
Reduced diluted shares while 0425.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
212.35%
10Y revenue/share CAGR 1.25-1.5x 0425.HK's 183.51%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
25.02%
5Y revenue/share CAGR under 50% of 0425.HK's 183.51%. Michael Burry would suspect a significant competitive gap or product weakness.
327.01%
3Y revenue/share CAGR above 1.5x 0425.HK's 183.51%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-1.34%
Negative 10Y OCF/share CAGR while 0425.HK stands at 843.40%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
5.04%
Below 50% of 0425.HK's 843.40%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-55.00%
Negative 3Y OCF/share CAGR while 0425.HK stands at 843.40%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-18.02%
Negative 10Y net income/share CAGR while 0425.HK is at 165.39%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-70.56%
Negative 5Y net income/share CAGR while 0425.HK is 165.39%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-37.01%
Negative 3Y CAGR while 0425.HK is 165.39%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-26.81%
We cut SG&A while 0425.HK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.